MedTrace Logo

Gene and Protein Expression Profiles After Treatment of Actinic Keratoses

NCT05740969 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-02-23

No results posted yet for this study

Summary

The primary aim of this study is to investigate the effect of 5-fluorouracil, imiquimod, and melatonin for actinic keratosis on immunological gene, and protein expressions profiles. Secondarily, the aim is to assess the effect of the treatment on the histopathology of actinic keratoses.

Conditions

  • Actinic Keratoses

Interventions

DRUG

5Fluorouracil

Cream

DRUG

Imiquimod

Cream

DRUG

Melatonin

Cream

Sponsors & Collaborators

  • Ismail Gögenur

    lead OTHER

Principal Investigators

  • Ismail A. Gögenur, MD, DMSc · Center For Surgical Science, Dept. of Surgery, Zealand University Hosptial

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2024-02-01
Completion
2024-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05740969 on ClinicalTrials.gov